Free Trial

Amneal Pharmaceuticals (AMRX) SEC Filings & 10K Form

Amneal Pharmaceuticals logo
$7.21 -0.08 (-1.10%)
Closing price 04:00 PM Eastern
Extended Trading
$7.38 +0.17 (+2.29%)
As of 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Amneal Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/13/2025
3:42 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:54 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:34 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
5:57 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:01 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:03 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:10 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
5:53 PM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
5:56 PM
Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
5:17 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
3:29 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
5:18 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
3:12 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:16 PM
Amneal Pharmaceuticals (Filer)
Form DEFA14A
03/17/2025
3:45 PM
Amneal Pharmaceuticals (Subject)
Patel Tushar Bhikhubhai (Filed by)
Form SCHEDULE 13D/A
03/14/2025
6:32 PM
Amneal Pharmaceuticals (Subject)
Patel Tushar Bhikhubhai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
3:11 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:16 PM
Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:17 PM
Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:17 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:18 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:18 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:21 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:53 PM
Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:31 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:33 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:11 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:12 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
9:00 AM
Amneal Pharmaceuticals (Subject)
Konidaris Tasos (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:03 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:58 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:59 PM
Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
5:13 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
7:59 AM
Amneal Pharmaceuticals (Subject)
UBS Group AG (Filed by)
Form SCHEDULE 13G/A
02/05/2025
3:31 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:49 PM
Amneal Pharmaceuticals (Subject)
Patel Dipan (Filed by)
Form SCHEDULE 13D/A
01/15/2025
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:25 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:22 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:48 PM
Amneal Pharmaceuticals (Subject)
Patel Gautam (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:41 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

11/25/2024
3:26 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:38 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
9:39 AM
Amneal Pharmaceuticals (Subject)
Kiely John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
1:01 PM
Amneal Pharmaceuticals (Subject)
Autor Deborah M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
12:49 PM
Amneal Pharmaceuticals (Subject)
Daly Jason B. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
5:08 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
5:51 PM
Amneal Pharmaceuticals (Subject)
Patel Chirag K. (Filed by)
Form SC 13D/A
10/30/2024
10:04 AM
Amneal Pharmaceuticals (Subject)
UBS Group AG (Filed by)
Form SCHEDULE 13G
10/01/2024
6:10 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
2:12 PM
Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
10:04 AM
Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:27 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMRX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners